Januvia (sitagliptin) is a prescription drug that’s used to treat type 2 diabetes. This drug can interact with other medications. For example, Januvia can interact with other diabetes medications and ...

Co says data presented at the 43rd Annual Meeting of the European Association for the Study of Diabetes demonstrated that, when used investigationally as initial therapy in combination with metformin, ...

These three NDAs of Sitagliptin (base) and combination franchise have been approved by the USFDA earlier through the 505 (b) (2) route. The Zituvio range of products contain active ingredients ...

New data from an investigational study released at the American Diabetes Association (ADA) 67th Annual Scientific Sessions showed that initial combination therapy with JANUVIA (sitagliptin) and ...

With the two active components, sitagliptin and metformin, Janumet has a comprehensive mechanism of action that targets all three key defects of T2DM for improved glycemic control: diminished insulin ...

Sitagliptin is prescribed metformin januvia 50mg people who still have high blood sugar, even though they have a sensible diet and exercise regularly. It comes as tablets that you swallow. Common side ...

Merck & Co., after settling with nearly two dozen drugmakers aiming to launch generics of its blockbuster Type 2 diabetes med Januvia, has successfully parried a Viatris patent assault in court. A U.S ...

In a report to the FDA, Merck says it has figured out how its blockbuster Type 2 diabetes drugs have become contaminated with nitrosamine. And the company has told the regulator that it can fix the ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the U.S. Court of Appeals for the Federal Circuit ruled in favor of the ...

As a new class of OADs, DPP-4 inhibitors have many important advantages over other currently available antidiabetic drugs. Compared with currently available insulin secretagogues, DPP-4 inhibitors, by ...